Pierluigi Giuseppe Manti, Sebastiano Trattaro, Davide Castaldi, Martina Pezzali, Lorenzo Spaggiari, Giuseppe Testa
Trends in molecular medicine 2022 JanThymic epithelial tumors (TETs) have been characterized at the molecular level through bioptic sections and cell lines. Despite these advances, there is a need for a more thorough characterization of the thymic stroma in thymoma, particularly because of the diversity of cell types that populate the tumor and the absence of a healthy thymic counterpart. Recent work on healthy pediatric thymi - both in vitro and at the single-cell level - now sets the stage for new studies on their neoplastic counterparts. Furthermore, general transcription factor IIi (GTF2I), a thymoma-specific oncogene, as well as some of its SNPs, are increasingly associated with autoimmune disease, a significant feature of thymomas. We summarize recent discoveries in the field and discuss the development of new targeted therapies. Copyright © 2021 Elsevier Ltd. All rights reserved.
Pierluigi Giuseppe Manti, Sebastiano Trattaro, Davide Castaldi, Martina Pezzali, Lorenzo Spaggiari, Giuseppe Testa. Thymic stroma and TFII-I: towards new targeted therapies. Trends in molecular medicine. 2022 Jan;28(1):67-78
PMID: 34865984
View Full Text